4.1 Article

Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

PDGFReceptor Signaling in Osteoblast Lineage Cells Controls Bone Resorption Through Upregulation ofCsf1Expression

Julia Brun et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Current treatment options for HCC: from pharmacokinetics to efficacy and adverse events in liver cirrhosis.

Giovanni Galati et al.

CURRENT DRUG METABOLISM (2020)

Review Oncology

New frontiers in the medical management of gastrointestinal stromal tumours

Alessandro Mazzocca et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2019)

Article Endocrinology & Metabolism

Osteoporosis and sarcopenia: two diseases or one?

Jean-Yves Reginster et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2016)

Article Geriatrics & Gerontology

Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib

Frederick Moryoussef et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)

Article Endocrinology & Metabolism

Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects

Kate Vandyke et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Article Oncology

An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity

Carla M. M. Prado et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)

Review Hematology

Dysregulation of bone remodeling by imatinib mesylate

Kate Vandyke et al.

BLOOD (2010)

Letter Medicine, General & Internal

Imatinib mesylate, increased bone formation, and secondary hyperparathyroidism

Andrew Grey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Endocrinology & Metabolism

Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA)

Wataru Ando et al.

JOURNAL OF BONE AND MINERAL METABOLISM (2006)

Article Medicine, General & Internal

Altered bone and mineral metabolism in patients receiving imatinib mesylate

E Berman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Review Pharmacology & Pharmacy

Clinical pharmacokinetics of imatinib

B Peng et al.

CLINICAL PHARMACOKINETICS (2005)